Stock Watch: Protocol Changes Preface Poor Trial Outcomes
Few If Any Changes To Clinical Trials Are Good
Executive Summary
It takes a lot of negotiation with regulators, advisory boards, and alignment between commercial and portfolio management teams to define and agree a clinical trial protocol. Why on earth would companies change it once a study is underway?